Nestlé

Lonza and Moderna Extend Covid Vaccine Collaboration

Swiss CDMO Lonza and US vaccine maker Moderna have extended and deepened their collaboration on the US biotech’s mRNA- based Covid-19 shot. The new agreement, which calls for the installation of three new production lines and a doubling of existing drug substance production at Lonza’s Visp, Switzerland, site, builds on a 10-year pact signed last year.

Nestlé Boosts Allergy Offering with Aimmune

Nestlé Health Science has agreed to buy Aimmune Therapeutics, a US biopharma and developer of food allergy treatments. The Swiss multinational food and beverage conglomerate already owns about 25.6% of the company through investments worth $473 million made between November 2016 and January 2020.

Interest in Consumer Drug Buys Waning?

World Alliance for Efficient Solutions

Pfizer to Launch Consumer Health Sale Soon?

Reckitt Benckiser in Talks to Buy Mead Johnson

Palm Oil Supplier’s Certificate Suspended

Nestle Boosts Skincare Business With Valeant Deal

Bayer and Reckitt Said Finalists for Merck & Co. Consumer Arm

Sanofi Share Buyback from L’Oreal could be “accretive,” CEO says

Sanofi Interested in Buying Back L'Oreal's $12 Billion Stake

European Companies Catch A Cold In Emerging Markets

Pfizer to Split Generic, Branded Drugs Units

GSK Says Executives Appear To Have Broken Chinese law

Roche Takes Its Hunt For A New Chairman Further Afield

China Launches Pharma Crackdown

China Says GSK Execs Confess To Bribery and Tax Crimes

Nestle Names Cell Scientist Catsicas as Technology Chief

Nestle Names Cantarell Head of Nutrition Unit

Nestle Invests in U.S. Medical Food for Alzheimer's

Danone Eyeing Latin American Assets post Nestle-Pfizer Deal

Nestle to buy Pfizer Nutrition for $11.9 bln

Nestle Near Deal for Pfizer's Baby Formula Unit

Bioplastics, Bioenergy and Biofuels in Global Land Use

Strategic Raw Materials

Novartis Expects Annual Cost Synergies of $350 Million From Alcon Integration

Novartis Won’t Go All-Cash on Alcon Deal

Novartis Hasn't Ruled out Keeping its 77% Alcon Stake

Novartis to Push Ahead With Disputed Alcon Buyout

Novartis Banking on Swiss Law for Alcon Deal

Cargill to Study SMART Audit, Decide How To Proceed

Novartis Still Seeking To Buy Out Alcon

Novartis Sticks To FY Goals As Q1 EPS Beats Forecast

Unilever to Resume Buying CPO if Sinar Mas Cleared

Cargill Warns Sinar Mas Over Illegal Logging Claim